TCTMD

Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk

Women at high bleeding risk (HBR) do not seem to experience more ischemic or bleeding events than men and may especially benefit from a regimen of short dual antiplatelet therapy (DAPT) after PCI, ...
TCTMD

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

PARIS, France—One month of dual antiplatelet therapy (DAPT) after PCI using contemporary stents not only is associated with similar rates of adverse clinical outcomes compared with 3 months or more in ...
Medscape

More Support for Shorter DAPT in High Bleeding Risk PCI

Select high bleeding risk (HBR) patients can safely receive just 1 or 3 months of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) without more ischemic events, ...
MedPage Today

Prasugrel Strategy Rolls Short DAPT and De-Escalation Into One

In acute coronary syndrome (ACS), a prasugrel (Effient)-based antiplatelet regimen passed muster for reducing bleeding without compromising ischemic protection after percutaneous coronary intervention ...
News Medical

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

A short-term course of dual antiplatelet therapy (DAPT) is non-inferior to a longer course in patients who have undergone placement of a particular kind of drug-eluting stent (DES), researchers ...
Pharmabiz

Abbott announces new late-breaking data show equivalent outcomes with shorter durations of anti-clotting drugs for Xience stent patients with high bleeding risk

Abbott announced new late-breaking data from two studies in the company’s Xience Short DAPT programme. The results demonstrate no difference between shorter courses of treatment with dual antiplatelet ...
MedPage Today

Pros and Cons of the ACC DAPT Risk Calculator App

Since the development of the first bare metal (BMS) and drug-eluting stents (DES), the literature and guidelines have debated how long to continue dual antiplatelet therapy (DAPT). The most recent ...
Morningstar

Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES

STARS DAPT is the first RCT designed to evaluate the non-inferiority of a P2Y 12 inhibitor–based SAPT strategy following a very short course of DAPT, compared with the current standard of care of ...
EurekAlert!

EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial

While dual antiplatelet therapy (DAPT) has long been the standard of care for the management of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), there is an ...
News Medical

New ESC Focused Update provides recommendations on DAPT in patients with coronary artery disease

The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal, and on the ESC website. The document was developed in ...
Medscape

ESC Guideline Update on Dual Antiplatelet Therapy in CAD

BARCELONA, SPAIN — The European Society of Cardiology has issued a new "focused update" on its guidelines on dual antiplatelet therapy (DAPT)—aspirin plus a P2Y 12 inhibitor—in coronary artery disease ...